Bryan Lawrence Oakcliff Capital Partners
Bryan Lawrence is the founder of Oakcliff Capital, a concentrated investment partnership in the value tradition. The firm’s filings typically show a short list of equities held with multi-year intent. Lawrence’s approach is often grouped with other high-conviction managers who prioritize a handful of well-understood businesses.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$2.58M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$5.27M |
| 2 |
AHGP
Alliance Holdings GP
AHGP
|
+$1.33M |
| 3 |
Star Group
SGU
|
+$984K |
| 4 |
Interactive Brokers
IBKR
|
+$835K |
| 5 |
TransDigm Group
TDG
|
+$168K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.07% |
| 2 | Financials | 17.62% |
| 3 | Industrials | 17.07% |
| 4 | Energy | 16.68% |
| 5 | Consumer Discretionary | 10.87% |
Similar funds
Bryan Lawrence's Q3 2017 Portfolio in Review
As of Q3 2017, Bryan Lawrence held 11 positions worth $119M, up 9.7% from $108M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Bryan Lawrence withdrew a net $3.87M in Q3 2017, reducing 5 holdings. Its largest reduction was Express Scripts Holding Company, cutting an estimated $5.27M.
By sector, the portfolio is most concentrated in Communication Services at 21% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
Against the trend, Bryan Lawrence added an estimated $2.58M to Axon Enterprise.
- Bryan Lawrence added most to Axon Enterprise in Q3 2017, an estimated $2.58M increase.
- Bryan Lawrence's biggest Q3 2017 reduction was Express Scripts Holding Company, cutting an estimated $5.27M.
- Bryan Lawrence's ten largest holdings make up 99% of its $119M portfolio in Q3 2017.
- Bryan Lawrence opened 0 new positions and closed 0 in Q3 2017.
- Bryan Lawrence's portfolio value rose 9.7% quarter-over-quarter to $119M.
Based on Oakcliff Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.